Chapter 16 Drugs Used for Anxiety Disorders

$2.50

Pay And Download The Complete Chapter Questions And Answers

Chapter 16  Drugs Used for Anxiety Disorders

 

 

Complete Chapter Questions And Answers
 

Sample Questions

 

MULTIPLE CHOICE

1. What is the recommended time over which antianxiety medications must be gradually tapered before discontinuation?
A.
1 week
B.
1 month
C.
6 months
D.
1 year

ANS: B

Feedback
A
One week is an inadequate interval for cessation of antianxiety medication therapy.
B
Withdrawal from medication should be done under a health care provider’s supervision. Withdrawal usually takes 4 weeks and requires a gradual reduction in dosage and greater intervals between medication administrations.
C
Six months is much longer than necessary for cessation of antianxiety medication therapy.
D
One year is much longer than necessary for cessation of antianxiety medication therapy.

DIF: Cognitive Level: Knowledge REF: 244
TOP: Nursing Process Step: Planning
MSC: NCLEX Client Needs Category: Psychosocial Integrity

2. Which is a benzodiazepine of choice when treating anxiety associated with alcohol withdrawal?
A.
Chlordiazepoxide (Librium)
B.
Oxazepam (Serax)
C.
Diazepam (Valium)
D.
Clorazepate (Tranxene)

ANS: B

Feedback
A
Chlordiazepoxide is not the drug of choice when treating anxiety associated with alcohol withdrawal.
B
Oxazepam and lorazepam are the drugs of choice in treating anxiety disorders because they have no active metabolites.
C
Diazepam has not been studied as fully as oxazepam in treating patients who have hepatic function impairment.
D
Clorazepate is not the drug of choice when treating anxiety associated with alcohol withdrawal.

DIF: Cognitive Level: Knowledge REF: 245
TOP: Nursing Process Step: Implementation
MSC: NCLEX Client Needs Category: Psychosocial Integrity

3. Which is the drug of choice to treat a patient with obsessive-compulsive disorder (OCD)?
A.
Lorazepam (Ativan)
B.
Buspirone (BuSpar)
C.
Fluvoxamine (Luvox)
D.
Hydroxyzine (Vistaril)

ANS: C

Feedback
A
Lorazepam does not treat the symptoms of OCD.
B
BuSpar does not treat the symptoms of OCD.
C
Fluvoxamine inhibits the reuptake of serotonin at the nerve endings, thus prolonging serotonin activity. Fluvoxamine is used for the treatment of OCD when the obsessions or compulsions cause marked distress or interfere substantially with social or occupational responsibilities. Fluvoxamine does not prevent the obsessions or compulsions; the therapeutic outcome of this drug is to assist the patient in their management.
D
Hydroxyzine does not treat the symptoms of OCD.

DIF: Cognitive Level: Comprehension REF: 247
TOP: Nursing Process Step: Implementation
MSC: NCLEX Client Needs Category: Psychosocial Integrity

4. The outcome statement for a patient suffering from anxiety disorder reads, “After 1 week on alprazolam (Xanax) therapy, patient will exhibit a manageable level of anxiety.” Which assessment finding validates that this outcome is met?
A.
Patient is unable to participate in group therapy conversations.
B.
Patient reports persistent fear about dying of a rare illness.
C.
Patient verifies family reunions trigger anxiety and excessive drinking.
D.
Patient reports sleeping better and increased interest in activities.

ANS: D

Feedback
A
Being unable to participate in group therapy indicates that the anxiety is not manageable.
B
Persistent fears indicate that the anxiety is not manageable.
C
Choosing inappropriate coping mechanisms for noncatastrophic events indicates that the anxiety is not manageable.
D
The primary therapeutic outcome expected from benzodiazepine antianxiety agents is a decrease in the level of anxiety to a manageable level. Physical signs of anxiety have decreased, and coping is improved.

DIF: Cognitive Level: Application REF: 244
TOP: Nursing Process Step: Evaluation
MSC: NCLEX Client Needs Category: Psychosocial Integrity

 

There are no reviews yet.

Add a review

Be the first to review “Chapter 16 Drugs Used for Anxiety Disorders”

Your email address will not be published. Required fields are marked *

Category: Tag:
Updating…
  • No products in the cart.